tetano
Editor, Senior Moderator
EClinicalMedicine
. 2020 Sep;26:100492.
doi: 10.1016/j.eclinm.2020.100492. Epub 2020 Aug 24.
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China
Hua Ye[SUP] 1 [/SUP], Chengguang Zhao[SUP] 1 2 3 [/SUP], Lehe Yang[SUP] 2 [/SUP], Wenwen Yu[SUP] 1 4 [/SUP], Zhefeng Leng[SUP] 4 [/SUP], Yangjie Sun[SUP] 1 [/SUP], Zhongxiang Xiao[SUP] 1 [/SUP], Xie Zhang[SUP] 1 [/SUP], Long Zheng[SUP] 1 [/SUP], Xinxin Ye[SUP] 1 [/SUP], Legui Zheng[SUP] 1 [/SUP], Xiaoying Huang[SUP] 2 [/SUP], Yuanrong Dai[SUP] 4 [/SUP], Jifa Li[SUP] 1 [/SUP]
Affiliations
Abstract
Background: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively.
Methods: In this retrospective, single-center cohort study, we included adult patients (≥ 18 years old) diagnosed as COVID-19 in Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. All the patients were discharged before March 31, 2020, and were re-tested for SARS-CoV-2 RNA by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) after meeting the discharge criteria. We retrospectively analyzed this cohort of 117 discharged patients and analyzed the differences between retest positive and negative patients in terms of demographics, clinical characteristics, laboratory findings, chest computed tomography (CT) features and treatment procedures.
Findings: Compared with the negative group, the positive group had a higher proportion of patients with comorbidities (Odds Ratio(OR) =2?12, 95% Confidence Interval(CI) 0?48-9?46; p = 0?029), longer hospital stay (OR=1?21, 95% CI 1?07-1?36; p = 0?008), a higher proportion of patients with lymphocytopenia (p = 0?036), a higher proportion of antibiotics treatment (p = 0?008) and glucocorticoids treatment (p = 0?003). Multivariable regression showed increasing odds of positive SARS-CoV-2 retest after discharge associated with longer hospital stay (OR=1?22, 95% CI 1?08-1?38; p = 0?001), and lymphocytopenia (OR=7?74, 95% CI 1?70-35?21; p = 0?008) on admission.
Interpretation: Patients with COVID-19 who met discharge criteria could still test positive for SARS-CoV-2 RNA. Longer hospital stay and lymphopenia could be potential risk factors for positive SARS-CoV-2 retest in COVID-19 patients after hospital discharge.
Funding: Natural Science Foundation of Zhejiang Province, Medical Scientific Research Fund of Zhejiang Province, Wenzhou science and technology project.
. 2020 Sep;26:100492.
doi: 10.1016/j.eclinm.2020.100492. Epub 2020 Aug 24.
Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China
Hua Ye[SUP] 1 [/SUP], Chengguang Zhao[SUP] 1 2 3 [/SUP], Lehe Yang[SUP] 2 [/SUP], Wenwen Yu[SUP] 1 4 [/SUP], Zhefeng Leng[SUP] 4 [/SUP], Yangjie Sun[SUP] 1 [/SUP], Zhongxiang Xiao[SUP] 1 [/SUP], Xie Zhang[SUP] 1 [/SUP], Long Zheng[SUP] 1 [/SUP], Xinxin Ye[SUP] 1 [/SUP], Legui Zheng[SUP] 1 [/SUP], Xiaoying Huang[SUP] 2 [/SUP], Yuanrong Dai[SUP] 4 [/SUP], Jifa Li[SUP] 1 [/SUP]
Affiliations
- PMID: 32864590
- PMCID: PMC7444491
- DOI: 10.1016/j.eclinm.2020.100492
Abstract
Background: It has been reported that a fraction of recovered coronavirus disease 2019(COVID-19) patients have retested positive for SARS-CoV-2. Clinical characteristics and risk factors for retesting positive have not been studied extensively.
Methods: In this retrospective, single-center cohort study, we included adult patients (≥ 18 years old) diagnosed as COVID-19 in Affiliated Yueqing Hospital, Wenzhou Medical University, Zhejiang, China. All the patients were discharged before March 31, 2020, and were re-tested for SARS-CoV-2 RNA by real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) after meeting the discharge criteria. We retrospectively analyzed this cohort of 117 discharged patients and analyzed the differences between retest positive and negative patients in terms of demographics, clinical characteristics, laboratory findings, chest computed tomography (CT) features and treatment procedures.
Findings: Compared with the negative group, the positive group had a higher proportion of patients with comorbidities (Odds Ratio(OR) =2?12, 95% Confidence Interval(CI) 0?48-9?46; p = 0?029), longer hospital stay (OR=1?21, 95% CI 1?07-1?36; p = 0?008), a higher proportion of patients with lymphocytopenia (p = 0?036), a higher proportion of antibiotics treatment (p = 0?008) and glucocorticoids treatment (p = 0?003). Multivariable regression showed increasing odds of positive SARS-CoV-2 retest after discharge associated with longer hospital stay (OR=1?22, 95% CI 1?08-1?38; p = 0?001), and lymphocytopenia (OR=7?74, 95% CI 1?70-35?21; p = 0?008) on admission.
Interpretation: Patients with COVID-19 who met discharge criteria could still test positive for SARS-CoV-2 RNA. Longer hospital stay and lymphopenia could be potential risk factors for positive SARS-CoV-2 retest in COVID-19 patients after hospital discharge.
Funding: Natural Science Foundation of Zhejiang Province, Medical Scientific Research Fund of Zhejiang Province, Wenzhou science and technology project.